US Military contributions to the global response to pandemic chikungunya (Q30224145)

10 June 2017

US Military contributions to the global response to pandemic chikungunya (English)

1 reference

10 June 2017

0 references

0 references

0 references

1 reference

Charles H Hoke

1

1 reference

10 June 2017

Judy Pace-Templeton

2

1 reference

10 June 2017

Phillip Pittman

3

1 reference

10 June 2017

Frank J Malinoski

4

1 reference

10 June 2017

Paul Gibbs

5

1 reference

10 June 2017

Tracy Ulderich

6

1 reference

10 June 2017

Michelle Mathers

7

1 reference

10 June 2017

Beverly Fogtman

8

1 reference

10 June 2017

Pamela Glass

9

1 reference

10 June 2017

David W Vaughn

10

1 reference

10 June 2017

language of work or name

English

0 references

publication date

29 August 2012

1 reference

10 June 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

10 June 2017

30

1 reference

10 June 2017

6713-6720

1 reference

10 June 2017

47

1 reference

on focus list of Wikimedia project

10 June 2017

ScienceSource

0 references

cites work

Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Tracking the re-emergence of epidemic chikungunya virus in Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Disappearance of Chikungunya virus from Bangkok

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Development of an attenuated strain of chikungunya virus for use in vaccine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Immunologic interference from sequential administration of live attenuated alphavirus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Chikungunya fever: an epidemiological review of a re-emerging infectious disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Chikungunya outbreaks--the globalization of vectorborne diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

A single mutation in chikungunya virus affects vector specificity and epidemic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

Transmission potential of chikungunya virus and control measures: the case of Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.025

10.1016/J.VACCINE.2012.08.025

7 January 2021

Identifiers

DOI

1 reference

10 June 2017

1 reference